ConductScience.org, home

Library / Trials

Bioactive Glass With or Without a Collagen Membrane for Periodontal Intrabony Defects

NCT07922577, Not applicable, Completed, Medical University of Bialystok

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleBioactive Glass With or Without a Collagen Membrane for Periodontal Intrabony DefectsClinicalTrials.gov
NCT numberNCT07922577ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment40 participants, actualClinicalTrials.gov
Lead sponsorMedical University of BialystokClinicalTrials.gov
ConditionsPeriodontitisClinicalTrials.gov
InterventionsPeriodontal regenerative surgery with bioactive glass alone, Periodontal regenerative surgery with bioactive glass and a collagen membraneClinicalTrials.gov
First posted2026-11-06ClinicalTrials.gov
Last updated2026-11-06ClinicalTrials.gov

Registered outcomes 6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in Clinical Attachment LevelBaseline (before surgery), 6 months and 12 years after surgery.
Clinical attachment level (CAL) was measured in millimeters as the distance from the cementoenamel junction to the bottom of the periodontal pocket at the treated intrabony defect site using a PCP-UNC15 periodontal probe. Measurements were performed by a calibrated examiner blinded to treatment allocation. Changes were calculated relative to baseline. A decrease in CAL indicates clinical attachment gain.
ClinicalTrials.gov
SecondaryChange in Probing DepthBaseline (before surgery), 6 months and 12 years after surgery.
Probing depth (PD) was measured in millimeters from the gingival margin to the bottom of the periodontal pocket using a PCP-UNC15 periodontal probe. The greatest probing depth within the pocket corresponding to the treated intrabony defect was recorded. Changes were assessed relative to baseline. A decrease indicates improvement.
ClinicalTrials.gov
SecondaryChange in Gingival RecessionBaseline (before surgery), 6 months and 12 years after surgery.
Gingival recession (GR) was measured in millimeters from the cementoenamel junction to the gingival margin using a PCP-UNC15 periodontal probe. Positive values indicated a gingival margin located apical to the cementoenamel junction. Changes at the treated site were assessed relative to baseline. An increase indicates greater recession.
ClinicalTrials.gov
SecondaryChange in Full-Mouth Plaque ScoreBaseline (before surgery), 6 months and 12 years after surgery.
Full-mouth plaque score (FMPS) was calculated as the percentage of examined sites with detectable plaque, assessed at six sites around each tooth present. Scores range from 0% to 100%, with higher values indicating more plaque. Changes were assessed relative to baseline.
ClinicalTrials.gov
SecondaryChange in Radiographic Intrabony Defect HeightBaseline (before surgery), 6 months and 12 years after surgery.
Radiographic intrabony defect height (Rx-OH) was measured in millimeters on standardized intraoral periapical radiographs. Changes were assessed relative to baseline. A decrease indicates a reduction in the radiographic vertical dimension of the defect.
ClinicalTrials.gov
SecondaryChange in Radiographic Intrabony Defect WidthBaseline (before surgery), 6 months and 12 years after surgery.
Radiographic intrabony defect width (Rx-OW) was measured in millimeters on standardized intraoral periapical radiographs. Changes were assessed relative to baseline. A decrease indicates a reduction in the radiographic horizontal dimension of the defect.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)